BioCentury
ARTICLE | Company News

Ferring sales and marketing update

March 9, 2015 7:00 AM UTC

Ferring launched Cortiment MMX budesonide in Europe to treat adults with active mild to moderate ulcerative colitis in cases where mesalazine has not been sufficient. The approved dose is a 9 mg tabl...